Continuing Medical Education Information

AACE Endocrine University

Event start date: 02/2/2023
Credit claim deadline: 12/31/2023

Statement of Need

Endocrine University® is designed to provide a forum for endocrinology fellows -in-training to enhance their endocrine curriculum, particularly in diabetes, thyroid, bone, and new technology which has become essential to the practice of endocrinology.

Target Audience:

This program is intended for first year Endocrine Fellows-in-Training.

Learning Objectives

By the end of the meeting, participants will be able to:

• Effectively utilize new skills and technology in diabetes and thyroid ultrasound.
• Apply the most up-to-date guidelines and evidence-based practices for the diagnosis and treatment of diabetes and thyroid disease.
• Integrate the latest evidence-based research for diagnosis and treatment of emerging areas of diabetes, thyroid, and bone related practice.

Accreditation and Designation Statements

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates this other (live virtual) activity for a maximum of 16 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure and Conflicts of Interest Policy:

The American Association of Clinical Endocrinology (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Commercial Support

This activity is supported by educational grants from the following:

• Abbott Diabetes Care
• Amgen
• Corcept Therapeutics
• Dexcom, Inc.
• Lilly USA, LLC
• Merck-Pfizer Diabetes Collaboration
• Novo Nordisk
• Recordati Rare Diseases
• Rhythm Pharmaceuticals
• Sandoz, Inc.
• Ultragenyx Pharmaceutical

Planning Committee

• Sara E. Lubitz, MD, FACE
• Matthew J. Levine, MD, FACE
• David Lieb, MD, FACP, FACE
• Michelle Lundholm, MD
• Pooja Luthra, MD, FACE
• Jawairia Shakil, MBBS
• Dace Trence, MD, MACE
• Geetha Gopalakrishnan, MD
• Sarah Mayson, MD

Planning Committee Disclosures

Faculty Disclosures

All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Reviewers

None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.